Heptares Therapeutics Extends Multi-FTE Chemistry Collaboration with O2h
News May 24, 2010
Executives from Heptares Therapeutics and Oxygen Healthcare (O2h) announced an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.
Dr. Miles Congreve, Head of Chemistry said, “We are happy to have signed this new contract with O2h; they have been a solid chemistry partner and have also supported us with some basic ADME, which helps to reduce discovery cycle times.”
Sunil Shah, CEO, O2h “We have had a successful partnership with Heptares Therapeutics and are delighted at this extension for the third year. Heptares has a very innovative technology that we are happy to have supported since inception and believe will lead to new GPCR drugs being discovered.”
Computers, like those that power self-driving cars, can be tricked into mistaking random scribbles for trains, fences and even school busses. People aren't supposed to be able to see how those images trip up computers but in a new study, Johns Hopkins University researchers show most people actually can.